MDM2 SUMOylates TP53 with SUMO2,3

Stable Identifier
R-HSA-2997706
Type
Reaction [transition]
Species
Homo sapiens
Compartment
Synonyms
Conjugation of SUMO2,3 to TP53
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
MDM2 in a complex with CDKN2A (p14-ARF) SUMOylates TP53 (p53) with SUMO2,3 at lysine-386 (Stindt et al. 2011, Hendriks et al. 2014, Tammsalu et al. 2014). SUMOylation decreases transcriptional activation by TP53 at some genes and decreases repression by TP53 at other genes (Stindt et al. 2011).
Literature References
PubMed ID Title Journal Year
21900752 MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity

Vigneron, AM, Carter, S, Ryan, KM, Vousden, KH, Stindt, MH

Cell Cycle 2011
24782567 Proteome-wide identification of SUMO2 modification sites

Tatham, MH, Hay, RT, Tammsalu, T, Ibrahim, AF, Jaffray, EG, Matic, I

Sci Signal 2014
25218447 Uncovering global SUMOylation signaling networks in a site-specific manner

Yang, B, Hendriks, IA, Verlaan-de Vries, M, Vertegaal, AC, D'Souza, RC, Mann, M

Nat. Struct. Mol. Biol. 2014
Participants
Participates
Catalyst Activity

SUMO transferase activity of p14-ARF:MDM2 [nucleoplasm]

Authored
Reviewed
Created
Cite Us!